- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.14 Å
- Oligo State
- hetero-1-1-1-mer
- Ligands
- 1 x GLC- GLC- GLC- GLC: alpha-D-glucopyranose-(1-4)-alpha-D-glucopyranose-(1-4)-alpha-D-glucopyranose-(1-4)-alpha-D-glucopyranose(Non-functional Binders)
- 40 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.2: 5 residues within 4Å:- Chain A: K.15, Y.17, N.18, D.296, K.297
Ligand excluded by PLIPEDO.3: 3 residues within 4Å:- Chain A: S.211, I.212, A.215
Ligand excluded by PLIPEDO.4: 7 residues within 4Å:- Chain A: K.15, G.16, W.230, V.293, K.297, P.298, L.299
Ligand excluded by PLIPEDO.5: 8 residues within 4Å:- Chain A: K.42, E.45, K.46, Q.49
- Chain C: R.9, E.13, D.364, Q.386
Ligand excluded by PLIPEDO.6: 6 residues within 4Å:- Chain A: L.121, L.122, L.135, E.138, L.139, K.142
Ligand excluded by PLIPEDO.7: 5 residues within 4Å:- Chain A: P.271, N.272, K.273, E.274, L.275
Ligand excluded by PLIPEDO.8: 6 residues within 4Å:- Chain A: D.95, Y.176, I.329, M.330, P.331, N.332
Ligand excluded by PLIPEDO.9: 6 residues within 4Å:- Chain A: A.301, E.308, A.312, I.317, A.318, M.321
Ligand excluded by PLIPEDO.10: 4 residues within 4Å:- Chain A: T.31, I.33, L.275, E.278
Ligand excluded by PLIPEDO.11: 4 residues within 4Å:- Chain A: E.130, E.131, P.133, A.134
Ligand excluded by PLIPEDO.12: 3 residues within 4Å:- Chain A: T.128, E.130, E.131
Ligand excluded by PLIPEDO.13: 6 residues within 4Å:- Chain A: G.13, D.14, Y.210, E.214, N.234, K.297
Ligand excluded by PLIPEDO.14: 7 residues within 4Å:- Chain A: E.44, W.62, E.153
- Ligands: GLC-GLC-GLC-GLC.1, GLC-GLC-GLC-GLC.1, GLC-GLC-GLC-GLC.1, GLC-GLC-GLC-GLC.1
Ligand excluded by PLIPEDO.15: 4 residues within 4Å:- Chain A: R.354, Q.355, T.356, E.359
Ligand excluded by PLIPEDO.16: 4 residues within 4Å:- Chain B: F.12, I.13, V.30, T.31
Ligand excluded by PLIPEDO.17: 3 residues within 4Å:- Chain B: K.8, D.9, K.11
Ligand excluded by PLIPEDO.18: 7 residues within 4Å:- Chain C: F.387, E.390, V.394, P.397, T.398, T.419, Y.420
Ligand excluded by PLIPEDO.19: 8 residues within 4Å:- Chain C: L.51, W.56, L.75, L.93, N.94, G.95, K.96
- Ligands: EDO.27
Ligand excluded by PLIPEDO.20: 5 residues within 4Å:- Chain C: V.23, F.52, K.311, E.313, Q.315
Ligand excluded by PLIPEDO.21: 6 residues within 4Å:- Chain C: V.25, Y.50, F.52, V.230, K.311
- Ligands: EDO.34
Ligand excluded by PLIPEDO.22: 6 residues within 4Å:- Chain C: K.135, K.311, A.312, E.313, Y.314, I.332
Ligand excluded by PLIPEDO.23: 3 residues within 4Å:- Chain C: Q.386, F.387, E.390
Ligand excluded by PLIPEDO.24: 3 residues within 4Å:- Chain C: T.8, R.9, D.10
Ligand excluded by PLIPEDO.25: 5 residues within 4Å:- Chain C: W.391, L.392, P.397, T.421, P.422
Ligand excluded by PLIPEDO.26: 3 residues within 4Å:- Chain C: M.16, R.19, P.401
Ligand excluded by PLIPEDO.27: 7 residues within 4Å:- Chain C: L.51, F.52, G.53, W.56, T.57, Q.97
- Ligands: EDO.19
Ligand excluded by PLIPEDO.28: 5 residues within 4Å:- Chain C: C.76, F.78, Q.90, F.122
- Ligands: EDO.30
Ligand excluded by PLIPEDO.29: 6 residues within 4Å:- Chain C: P.236, R.237, M.266, K.267, T.269, Q.283
Ligand excluded by PLIPEDO.30: 5 residues within 4Å:- Chain C: F.78, M.88, K.120, F.122
- Ligands: EDO.28
Ligand excluded by PLIPEDO.31: 6 residues within 4Å:- Chain C: K.30, V.31, D.154, C.156, Q.258, S.308
Ligand excluded by PLIPEDO.32: 5 residues within 4Å:- Chain C: A.158, S.159, D.215, G.216, Y.217
Ligand excluded by PLIPEDO.33: 4 residues within 4Å:- Chain C: V.131, P.326, T.328, P.329
Ligand excluded by PLIPEDO.34: 9 residues within 4Å:- Chain C: L.27, Y.50, H.180, Q.192, W.193, G.194, A.195, V.230
- Ligands: EDO.21
Ligand excluded by PLIPEDO.35: 8 residues within 4Å:- Chain C: Q.33, R.41, F.42, C.44, F.166, R.168, L.259
- Chain E: G.8
Ligand excluded by PLIPEDO.36: 2 residues within 4Å:- Chain C: S.208, E.209
Ligand excluded by PLIPEDO.37: 9 residues within 4Å:- Chain C: F.166, N.167, R.168, K.261, D.300, C.303, W.304, T.305
- Ligands: EDO.41
Ligand excluded by PLIPEDO.38: 6 residues within 4Å:- Chain C: E.313, Y.314, Q.315, A.413, T.414, G.415
Ligand excluded by PLIPEDO.39: 4 residues within 4Å:- Chain C: N.38, E.39, K.40, F.105
Ligand excluded by PLIPEDO.40: 7 residues within 4Å:- Chain C: C.48, Y.50, Y.98, A.100, T.191, Q.192, W.193
Ligand excluded by PLIPEDO.41: 6 residues within 4Å:- Chain C: N.167, Q.246, K.261, D.300, C.303
- Ligands: EDO.37
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yuan, Z. et al., Structure and Function of the Su(H)-Hairless Repressor Complex, the Major Antagonist of Notch Signaling in Drosophila melanogaster. Plos Biol. (2016)
- Release Date
- 2016-06-15
- Peptides
- Maltose-binding periplasmic protein: A
Protein hairless: B
Suppressor of hairless protein: C - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
DC
E
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.14 Å
- Oligo State
- hetero-1-1-1-mer
- Ligands
- 1 x GLC- GLC- GLC- GLC: alpha-D-glucopyranose-(1-4)-alpha-D-glucopyranose-(1-4)-alpha-D-glucopyranose-(1-4)-alpha-D-glucopyranose(Non-functional Binders)
- 40 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yuan, Z. et al., Structure and Function of the Su(H)-Hairless Repressor Complex, the Major Antagonist of Notch Signaling in Drosophila melanogaster. Plos Biol. (2016)
- Release Date
- 2016-06-15
- Peptides
- Maltose-binding periplasmic protein: A
Protein hairless: B
Suppressor of hairless protein: C - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
DC
E